HRTX compared with SSYS: revenue, margins and what each company keeps, and the suppliers and customers both name

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

SSYSStratasys Ltd.

Mkt capRevenueRevenue

Compare

HRTXHeron Therapeutics, Inc.

SSYSStratasys Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

HRTXHeron Therapeutics, Inc.

0.28▼−1.12%· post 0.30

Mkt cap$54.1MRevenue$38MQ2 FY26Revenue$155MFY25

SSYSStratasys Ltd.

6.82▼−2.29%· post 6.89

ClosedNov 4 '26

Mkt cap$601.0MRevenue—Revenue—

Compare

ClosedNov 4 '26

HRTXHeron Therapeutics, Inc.

SSYSStratasys Ltd.

0.28▼−1.12%post 0.30

Price

6.82▼−2.29%post 6.89

$54.1M

Mkt cap

$601.0M

Q2 FY26$38M

Revenue

—

FY25$155M

Revenue

—

HRTX0.28▼−1.12%vsSSYS6.82▼−2.29%ClosedNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

HRTX: latest quarter is a loss; flow not drawable. SSYS: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only HRTX 0

None

Shared 0

No disclosed counterparties: HRTX.

Only SSYS 1

CLGNCollPlant Biotechnologiescustomer

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

HRTX, solidSSYS, dashed